VHL Polyclonal Antibody, 100ul[BT-AP09520] Modified Oligos including proliferation

including proliferation

Signal transducer and activator of transcription that mediates signaling by type I IFNs (IFN-alpha and IFN-beta)

The transcripts also differ in their 3'-non coding regions by the use of two alternative poly(A) signals

which is a member of the leukocyte receptor complex protein family that plays critical roles in the regulation of both innate and adaptive immune responses

VHL Polyclonal Antibody, 100ul[BT-AP09520] Modified Oligos including proliferationVon Hippel Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL is the basis of familial inheritance of VHL syndrome. The protein encoded by VHL is a component of the protein complex that includes elongin B, elongin C, and cullin 2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia